News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
818,594 Results
Type
Article (74962)
Company Profile (644)
Press Release (742988)
Multimedia
Podcasts (124)
Webinars (14)
Section
Business (227849)
Career Advice (3733)
Deals (39376)
Drug Delivery (129)
Drug Development (89465)
Employer Resources (198)
FDA (17874)
Job Trends (17146)
News (388424)
Policy (38861)
Tag
Academia (2999)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (94)
Alliances (56060)
ALS (99)
Alzheimer's disease (1501)
Antibody-drug conjugate (ADC) (156)
Approvals (17840)
Artificial intelligence (300)
Autoimmune disease (28)
Automation (16)
Bankruptcy (403)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (119)
Biotechnology (440)
Bladder cancer (85)
Brain cancer (32)
Breast cancer (301)
Cancer (2429)
Cardiovascular disease (204)
Career advice (3181)
Career pathing (34)
CAR-T (173)
Cell therapy (480)
Cervical cancer (21)
Clinical research (72277)
Collaboration (910)
Compensation (548)
Complete response letters (30)
COVID-19 (2866)
CRISPR (48)
C-suite (265)
Cystic fibrosis (107)
Data (2266)
Decentralized trials (2)
Denatured (42)
Depression (55)
Diabetes (297)
Diagnostics (6915)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (133)
Drug pricing (126)
Drug shortages (33)
Duchenne muscular dystrophy (101)
Earnings (94070)
Editorial (44)
Employer branding (25)
Employer resources (167)
Events (128945)
Executive appointments (773)
FDA (19201)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (808)
Gene editing (119)
Generative AI (28)
Gene therapy (354)
GLP-1 (850)
Government (5118)
Grass and pollen (6)
Guidances (65)
Healthcare (20874)
Huntington's disease (25)
IgA nephropathy (31)
Immunology and inflammation (146)
Indications (30)
Infectious disease (3026)
Inflammatory bowel disease (153)
Inflation Reduction Act (11)
Influenza (56)
Intellectual property (101)
Interviews (728)
IPO (17752)
IRA (51)
Job creations (5001)
Job search strategy (2601)
Kidney cancer (11)
Labor market (42)
Layoffs (553)
Leadership (24)
Legal (9934)
Liver cancer (81)
Lung cancer (345)
Lymphoma (159)
Machine learning (7)
Management (65)
Manufacturing (343)
MASH (75)
Medical device (14620)
Medtech (14625)
Mergers & acquisitions (22166)
Metabolic disorders (786)
Multiple sclerosis (87)
NASH (23)
Neurodegenerative disease (113)
Neuropsychiatric disorders (34)
Neuroscience (2104)
NextGen: Class of 2025 (7638)
Non-profit (5080)
Now hiring (40)
Obesity (423)
Opinion (275)
Ovarian cancer (78)
Pain (99)
Pancreatic cancer (86)
Parkinson's disease (160)
Partnered (22)
Patents (250)
Patient recruitment (116)
Peanut (51)
People (64164)
Pharmaceutical (133)
Pharmacy benefit managers (21)
Phase I (22327)
Phase II (31505)
Phase III (23777)
Pipeline (1252)
Policy (170)
Postmarket research (3282)
Preclinical (9865)
Press Release (72)
Prostate cancer (113)
Psychedelics (38)
Radiopharmaceuticals (269)
Rare diseases (429)
Real estate (7163)
Recruiting (75)
Regulatory (26127)
Reports (57)
Research institute (2655)
Resumes & cover letters (582)
Rett syndrome (5)
RNA editing (5)
RSV (50)
Schizophrenia (81)
Series A (143)
Series B (91)
Service/supplier (26)
Sickle cell disease (58)
Special edition (18)
Spinal muscular atrophy (165)
Sponsored (34)
Startups (4202)
State (2)
Stomach cancer (16)
Supply chain (75)
Tariffs (45)
The Weekly (80)
Vaccines (812)
Venture capitalists (44)
Weight loss (304)
Women's health (38)
Worklife (20)
Date
Today (212)
Last 7 days (944)
Last 30 days (2841)
Last 365 days (35454)
2025 (11519)
2024 (37899)
2023 (42567)
2022 (53926)
2021 (58723)
2020 (57663)
2019 (51308)
2018 (39093)
2017 (36860)
2016 (37777)
2015 (43769)
2014 (38491)
2013 (34493)
2012 (36409)
2011 (36519)
2010 (35991)
Location
Africa (1197)
Alabama (60)
Alaska (7)
Arizona (248)
Arkansas (14)
Asia (48758)
Australia (8410)
California (6425)
Canada (2057)
China (562)
Colorado (284)
Connecticut (301)
Delaware (157)
Europe (110287)
Florida (941)
Georgia (220)
Hawaii (1)
Idaho (63)
Illinois (613)
India (30)
Indiana (331)
Iowa (12)
Japan (168)
Kansas (110)
Kentucky (27)
Louisiana (14)
Maine (70)
Maryland (967)
Massachusetts (4936)
Michigan (246)
Minnesota (419)
Mississippi (2)
Missouri (92)
Montana (31)
Nebraska (26)
Nevada (65)
New Hampshire (69)
New Jersey (1820)
New Mexico (31)
New York (1821)
North Carolina (1122)
North Dakota (9)
Northern California (2749)
Ohio (219)
Oklahoma (15)
Oregon (46)
Pennsylvania (1419)
Puerto Rico (13)
Rhode Island (36)
South America (1569)
South Carolina (24)
South Dakota (1)
Southern California (2379)
Tennessee (104)
Texas (956)
United States (24655)
Utah (191)
Virginia (169)
Washington D.C. (69)
Washington State (600)
West Virginia (3)
Wisconsin (67)
818,594 Results for "harbin pharmaceutical group holding co ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
WORK Medical Technology Group LTD Announces Strategic Partnership with Shanghai Chartwell Medical Device Co., Ltd.
March 3, 2025
·
5 min read
BioCapital
Vanda Pharmaceuticals Confirms Receipt of Unsolicited, Non-Binding Indication of Interest from Cycle Group Holdings Ltd.
Vanda Pharmaceuticals Inc. confirmed that it has received an unsolicited, non-binding indication of interest from Cycle Group Holdings Ltd. to acquire the Company for $8.00 per share in cash.
June 6, 2024
·
3 min read
Press Releases
Lakeside Holding Enters Medical Logistics Sector with Acquisition of Hupan Pharmaceutical (Hubei) Co., Ltd.
November 11, 2024
·
4 min read
Press Releases
Vanda Pharmaceuticals Confirms Receipt of Economically Identical Unsolicited, Non-Binding Proposal from Cycle Group Holdings Ltd.
October 15, 2024
·
3 min read
Press Releases
Merck Enters Exclusive License Agreement for HRS-5346, an Investigational Oral Lipoprotein(a) Inhibitor, for Cardiovascular Disease from Jiangsu Hengrui Pharmaceuticals Co., Ltd.
March 25, 2025
·
5 min read
Press Releases
Basel Medical Group Ltd Prices US$8,820,000 Initial Public Offering
February 26, 2025
·
5 min read
BGI-HL OHA Lab inaugurated in Harbin, initiating colorectal cancer risk assessment for 800,000
On May 10, 2024, the BGI-Heilongjiang Omics Health Axis Intelligent Laboratory was inaugurated in Harbin, Heilongjiang province, China, marking a significant advance in the province’s efforts to address public health challenges.
May 13, 2024
·
2 min read
Press Releases
KRTL Holding Group Announces KRTL Biotech Inc. Signs MOU with Industria Químico Farmacéutica Sigma Corp. S.R.L. to Pursue Strategic International Merger
March 25, 2025
·
3 min read
Press Releases
Duchesnay Pharmaceutical Group creates Advisory Board to help guide the Group’s growth and success
April 16, 2025
·
5 min read
Press Releases
Qilian International Holding Group Ltd. Announces Trading Ticker Symbol to “BGM”
August 13, 2024
·
2 min read
1 of 81,860
Next
